NCT07303114Recruiting
Missed Opportunities for HIV Screening in General Practice
Missed Opportunities for HIV Screening in General Practice - A Retrospective Study
Source: ClinicalTrials.gov · Last updated 5 Jan 2026
Brief summary (registry, in English)
The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 11 Dec 2025
- Start date
- 14 Apr 2025
- Primary completion date
- Jul 2026
- Lead sponsor
- University Hospital, Strasbourg, France
- Diseases
- HIV
- NCT number
- NCT07303114
What you commit to
- Study type: Observational
- Planned participants: 50
- From 14 Apr 2025 to the primary completion date, Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- -Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.
Who the study is looking for
- Adult subject (≥18 years)
- diagnosed with HIV infection between January 1, 2021, and July 30, 2024
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France Coordinator of this site? Confirm its status | Strasbourg | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.